Characteristics at baseline, at week 24, and at last follow-up for nonresponders (n = 13)
| Characteristics . | Baseline, median (range) . | Week 24, median (range) . | P* . | Last follow-up, median (range) . | P* . |
|---|---|---|---|---|---|
| Symptom score | 13 (6-41) | 7 (3-13) | .109 | 8 (3-20) | .212 |
| IL-6, pg/mL | 20.7 (7.7-61.9) | 29.5 (8.8-42.8) | .735 | 29.7 (2.1-70.3) | 1.000 |
| Hemoglobin, g/L | 102.5 (73-141) | 86 (67-133) | .753 | 109 (67-135) | .374 |
| CRP, mg/L | 85.7 (1.6-119.2) | 93.0 (40.5-112.2) | .463 | 73.3 (2.6-176.0) | .779 |
| ESR, mm/h | 102 (2-140) | 102.5 (27-140) | .500 | 90 (11-140) | .161 |
| Albumin, g/L | 31 (24-43) | 33 (31-41) | .043 | 35.5 (27-46) | .018 |
| IgG, g/L | 36.5 (5.3-85.1) | 21.9 (7.5-44.1) | .028 | 21.7 (5.3-35.9) | .008 |
| Characteristics . | Baseline, median (range) . | Week 24, median (range) . | P* . | Last follow-up, median (range) . | P* . |
|---|---|---|---|---|---|
| Symptom score | 13 (6-41) | 7 (3-13) | .109 | 8 (3-20) | .212 |
| IL-6, pg/mL | 20.7 (7.7-61.9) | 29.5 (8.8-42.8) | .735 | 29.7 (2.1-70.3) | 1.000 |
| Hemoglobin, g/L | 102.5 (73-141) | 86 (67-133) | .753 | 109 (67-135) | .374 |
| CRP, mg/L | 85.7 (1.6-119.2) | 93.0 (40.5-112.2) | .463 | 73.3 (2.6-176.0) | .779 |
| ESR, mm/h | 102 (2-140) | 102.5 (27-140) | .500 | 90 (11-140) | .161 |
| Albumin, g/L | 31 (24-43) | 33 (31-41) | .043 | 35.5 (27-46) | .018 |
| IgG, g/L | 36.5 (5.3-85.1) | 21.9 (7.5-44.1) | .028 | 21.7 (5.3-35.9) | .008 |
Compared with baseline.